Delivery Order SPE2DB20D2014-SPE2DB24FC70S

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,172.96 firm fixed-price delivery order is for the supply of JANUMET XR 50-1,000 MG tablets. The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,922.35, is for the delivery of JANUMET XR 100-1,000 mg tablets in quantities of 90 per order. This appears to be a single delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,546.26, is for the delivery of JANUMET XR 50-1,000 mg tablets. The contract has an ultimate completion date of November 6, 2023 and is a firm fixed-price delivery order. This contract award is associated with a larger Indefinite Delivery Contract (IDC) the company holds with the DLA, valued at $999,999,999 and...
This federal contract award, valued at $11,222.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, with a period of performance through January 27, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award, valued at $61,956.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 26, 2024. The award is not associated with a set-aside program and is part of a larger Indefinite...
This federal contract award, valued at $36,954.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, and has an ultimate completion date of June 6, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,952.59, is for the delivery of JANUMET XR 50-1,000 MG TABLET 1000S. The contract has an ultimate completion date of November 29, 2023 and is a Firm Fixed Price Delivery Order contract. This contract award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,566.46, is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of January 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,745.04 to AmerisourceBergen Drug Corp, a leading global pharmaceutical distributor, to provide JANUMET XR 50-1,000 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the prime contractor to deliver a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLETS in quantities of 180 per order. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,586.27 and a period of performance through May 16, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC70S
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of JANUMET XR 50-1,000 MG tablets. The $5,809.20 firm fixed-price delivery order is a component of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies. This contract does not have a set-aside designation. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries across various locations and healthcare settings.

Generated 11/7/24, 9:22 AM